Hypothermia and operative mortality during on-pump coronary artery bypass grafting  by Greason, Kevin L. et al.
Acquired Cardiovascular Disease Greason et al
A
C
DHypothermia and operative mortality during on-pump coronary
artery bypass graftingKevin L. Greason, MD,a Sunghee Kim,b Rakesh M. Suri, MD,a Amelia S. Wallace, BSPH,b and
Brian R. Englum, MDbFrom th
Duke
The pre
Disclosu
the A
Trial,
nothin
Receive
public
Address
Mayo
mayo
0022-52
Copyrig
http://dx
2712Objective: Controversy surrounds the effect of hypothermia on operative mortality during cardiac surgery. The
present study accessed a large clinical database of coronary artery bypass graft operations to address the issue.
Methods: A retrospective review of the Society of Thoracic Surgeons Adult Cardiac Surgery Database
identified patients treated with isolated, nonemergency, on-pump coronary artery bypass grafting from July
2011 to December 2012. The patients were divided into 3 groups according to their lowest core temperature dur-
ing the procedure: moderate hypothermia (34C), mild hypothermia (>34C but 36C), and normothermia
(>36C). The primary endpoint of the study was operative mortality, defined according to the Database criteria.
Results: During the study period, 142,541 patients were available for analysis; 94,777 (66.5%) received
moderate hypothermia, 42,750 (30.3%) mild hypothermia, and 5014 (3.5%) normothermia. Operativemortality
occurred in 1394 patients (1.5%) in the moderate hypothermia, 534 (1.3%) in the mild hypothermia, and 105
(2.1%) in the normothermia group. Multivariate analysis identified hypothermia (both mild [odds ratio, 0.66;
95% confidence interval, 0.54-0.81; P< .0001] and moderate [odds ratio, 0.73; 95% confidence interval,
0.60-0.89; P¼ .0015]) was protective against operativemortality compared with normothermia. No incremental
benefit was noted between the different hypothermia grades (P ¼ .0827).
Conclusions:Most patients receive hypothermia during on-pump coronary artery bypass grafting. Hypothermia
is protective against operative mortality compared with normothermia in such patients. Moderate hypothermia
does not provide additional survival benefit. (J Thorac Cardiovasc Surg 2014;148:2712-8)See related commentary on pages 2718-9.Controversy exists about the risks and benefits of
hypothermia during cardiac surgery.1,2 Ho and Tan3
reviewed the effect of hypothermia on cardiac operative
mortality in a 2009 meta-analysis and identified 37 reports
totaling 6444 patients. The general conclusion was that
normothermia during cardiopulmonary bypass in adult
cardiac surgery was as safe as that of hypothermia.
Importantly, in that meta-analysis, more than one half of
the studies contained<100 patients and therefore lacked
an adequate sample size to address the issue. The Society
of Thoracic Surgeons (STS) Adult Cardiac Surgery
Database (STS-ACSD) began collecting lowest coree Division of Cardiovascular Surgery,a Mayo Clinic, Rochester, Minn; and
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The Journal of Thoracic and Cardiovascular Surtemperature data during the procedure in July 2011. The
addition of this field to the database has offered an
opportunity to study the effect of hypothermia on
operative mortality during cardiac surgery in a large patient
population.METHODS
The Duke University Health System institutional review board
declared this research exempt from review owing to the de-identified
nature of the STS-ACSD. Funding limitations allowed analysis of only
on-pump coronary artery bypass grafting (CABG). The STS-ACSD was
reviewed for all patients treated with isolated CABG from July 1, 2011
to December 31, 2012. Of the 216,321 patients identified, 73,780 pa-
tients (34.1%) were excluded to develop a more homogenous cohort of
stable, nonemergency patients for evaluation (Figure 1). No exclusion
criteria were used at the hospital level; however, some hospitals were
excluded from the analysis on the basis of the applied patient exclusion
criteria.
The patients were divided into 3 groups according to the lowest core
temperature during the procedure (STS-ACSD, version 2.73, sequence
no. 2780): moderate hypothermia (34C), mild hypothermia (>34C
and 36C), or normothermia (>36C). The distinction between mild
and moderate hypothermia was determined by institutional practice. The
patient characteristics studied were the standard STS risk model covariates
(ie, risk calculator variables) and additional non–risk model covariates
(Table 1), which also included the hospital CABG volume.4
The primary endpoint of the present study was operative mortality,
which was defined as operative death (sequence no. 6390), discharge death
(no. 6370), or death at 30 days after surgery (no. 6380). The secondary
individual endpoints were permanent stoke (no. 6030) and reoperation
for bleeding or tamponade (no. 5760). A combined infection endpoint
was also used and consisted of the individual endpoints of deep sternalgery c December 2014
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
OR ¼ odds ratio
STS ¼ Society of Thoracic Surgeons
STS-ACSD ¼ Society of Thoracic Surgeons Adult
Cardiac Surgery Database
Greason et al Acquired Cardiovascular Diseaseinfection (no. 5860), mediastinitis (no. 5870), pneumonia (no. 6150), and
sepsis (no. 6010).
Descriptive statistics for categorical variables are reported as counts and
percentages and continuous variables as the mean  standard deviation
and/or median and interquartile range. Categorical variables were
compared using the chi-square test and continuous variables using the
Kruskal-Wallis test.
Univariate and multivariate associations between the 4 endpoints and
the 3 perfusion temperature groups were assessed using logistic regression
analysis with the generalized estimating equation. To compare mild or
moderate hypothermia with normothermia on each outcome, multivariate
models were adjusted for the STS risk model covariates and non–risk
model covariates, in addition to the 3 perfusion temperature groups.
Missing covariates were imputed using most common category for
categorical covariates and group-specific medians for continuous
covariates. All continuous covariates were tested for linearity, and
nonlinear relationships were accounted for using flexible splines, including
linear splines or quadratic polynomial. All statistical tests were 2-sided,
with the a level set at 0.05 for statistical significance. All analyses were
performed using SAS, version 9.3 (SAS Institute, Cary, NC).FIGURE 1. Algorithm describing patient exclusion process. CABG,
Coronary artery bypass grafting; STS-ACSD, Society of Thoracic Surgeons
Adult Cardiac Surgery Database.
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DRESULTS
The study group included 142,541 patients treated
with on-pump, nonemergency, isolated CABG. During
cardiopulmonary bypass, 94,777 patients (66.5%) received
moderate hypothermia, 42,750 (30.0%) mild hypothermia,
and 5014 (3.5%) normothermia. A histogram of the lowest
core temperature of the study group during the procedure is
shown in Figure 2. The STS patient risk model covariates
are listed as patient characteristics in Table 2. The operative
data are reported in Table 3.
Operative mortality occurred in 1394 patients (1.5%) in
the moderate hypothermia group, 534 (1.3%) in the mild
hypothermia group, and 105 (2.1%) in the normothermia
group. Stroke occurred in 1257 patients (1.3%) in the
moderate group, 495 (1.2%) in the mild group, and 57
(1.1%) in the normothermia group. Reoperation occurred
in 1662 (1.8%) in the moderate group, 716 (1.7%) in the
mild group, and 99 (2.0%) in the normothermia group
(P ¼ .025). Finally, infection occurred in 3189 (3.4%) in
the moderate group, 1318 (3.1%) in the mild group, and
161 (3.2%) in the normothermia group.
Univariate analysis identified mild hypothermia to be
protective against operative mortality compared with
normothermia (odds ratio [OR], 0.60; 95% confidence
interval [CI], 0.49-0.72; P < .0001) and moderateThe Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 6 2713
TABLE 1. Society of Thoracic Surgeons non–risk model covariates
Age by group:<55, 55-64, 65-74, and 75 y (STS-ACSD no. 140)
History of smoking (STS-ACSD nos. 650 and 661)
No. of distal anastomoses with venous conduit (STS-ACSD no. 3200)
No. of distal anastomoses with arterial conduit (STS-ACSD no. 3190)
Dyslipidemia (STS-ACSD no. 800)
Radial arterial used for grafts (STS-ACSD no. 3260)
Preoperative medication, b-blocker (STS-ACSD no. 1710)
Preoperative medication, ACE inhibitor or ARB within 48 h (STS-ACSD
no. 1730)
Preoperative medication, anticoagulant (STS-ACSD nos. 1750, 1780,
1850, 1880, 1900)
Preoperative medication, aspirin (STS-ACSD no. 1820)
Preoperative medication, lipid lowering (STS-ACSD no. 1830)
Proper antibiotic administration (STS-ACSD nos. 2710 and 2720)
STS-ACSD, Society Thoracic Surgeons Adult Cardiac Surgery Database, version
2.73; ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker.
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Dhypothermia (OR, 0.86; 95% CI, 0.77-0.95; P ¼ .0028).
Furthermore, mild hypothermia was protective against
stroke compared with moderate hypothermia (OR, 0.87;
95% CI, 0.77-0.97; P ¼ .0125). Moderate hypothermia
was protective against operative mortality compared with
normothermia (OR, 0.70; 95% CI, 0.58-0.84; P ¼ .0002).
Additional univariate analyses of perfusion temperature
and endpoints are reported in Table 4.
Multivariate analysis identified mild hypothermia was
protective against operative mortality compared with
normothermia (OR, 0.66; 95% CI, 0.54-0.81; P<.0001).
Moderate hypothermia was also protective against
mortality compared with normothermia (OR, 0.73; 95%
CI, 0.60-0.89; P ¼ .0015). Mild hypothermia was not
significantly protective against operative mortality
compared with moderate hypothermia (P ¼ .0827). No
other perfusion temperature-related variables were protec-
tive of the primary or secondary endpoints (Table 5).FIGURE 2. Histogram of lowest patient temperature during on-pump coronar
Std Dev, Standard deviation.
2714 The Journal of Thoracic and Cardiovascular SurDISCUSSION
The effect of hypothermia during cardiac surgery is
controversial, and current data have provided conflicting
guidance. With a small anticipated effect size, most studies
have lacked an adequate sample size to evaluate the
question. The present study leveraged the large patient vol-
ume in the STS-ACSD to evaluate the effect of hypothermia
in patients undergoing on-pump CABG. In a group of
142,541 patients, 96.5% of the patients received
hypothermia (36C), which was protective against
mortality compared with normothermia. This held true in
multivariate analysis of both mild hypothermia (>34C
and 36C; OR, 0.66; 95% CI, 0.54-0.81; P<.0001) and
moderate hypothermia (34C; OR, 0.73; 95% CI,
0.60-0.89; P ¼ .0015). No benefit was seen for operative
mortality, however, in the comparison of mild and moderate
hypothermia (P ¼ .0827).
An attempt was made to create study cohorts that were as
homogeneous as possible. In doing so, 73,780 patients
(34.1%) and 29 hospitals (2.7%) were excluded from the
present study. These are significant numbers; however, the
covariates used to exclude the patients and hospitals were
clearly variables that would have confounded our analysis.
Most are known to be clinically significant predictors of
operative mortality, and, hence, their presence could have
contaminated the outcome analysis. Examples of such
variables include reoperation (operative mortality, OR,
3.13), shock (OR, 2.9), and emergency status with
resuscitation or salvage (OR, 8.00).4 Exclusion of these
types of patients from the analysis seemed reasonable and
still left a study group of>142,000 patients.
An important issue to consider is what constitutes
normothermia. Mackowiak and colleagues5 studied 700
temperature recordings from 148 healthy patients. They
reported a mean temperature of 36.8C  0.4C. Thus,y artery bypass grafting for the entire study group (n ¼ 142,541 patients).
gery c December 2014
TABLE 2. Society of Thoracic Surgeons risk model covariates according to lowest core temperature during the procedure
Variable
Moderate hypothermia
(n ¼ 94,777)
Mild hypothermia
(n ¼ 42,750)
Normothermia
(n ¼ 5014) P value
Continuous variables
Age (y) <.0001
Mean  SD 65.1  10.3 64.3  10.4 63.7  10.7
Median (IQR) 65 (58-73) 65 (57-72) 64 (56-71)
BSA (m2) <.0001
Mean  SD 2.00  0.24 2.03  0.25 2.05  0.25
Median (IQR) 2.00 (1.84-2.16) 2.03 (1.87-2.19) 2.05 (1.87-2.21)
Last preoperative creatinine (mg/dL) .0150
Mean  SD 1.17  0.99 1.16  0.98 1.16  0.94
Median (IQR) 1.0 (0.80-1.2) 1.00 (0.80-1.20) 1.00 (0.80-1.20)
Ejection fraction (%) <.0001
Mean  SD 52.5  12.1 52.5  11.9 51.0  12.9
Median (IQR) 55 (45-60) 55 (45-60) 55 (44-60)
Categorical variables
Female sex 24,887 (26.26) 10,443 (24.43) 1252 (24.97) <.0001
White race 76,777 (81.01) 35,665 (83.43) 4237 (84.50) <.0001
Smoking history* 31,803 (33.56) 14,284 (33.41) 1666 (33.23) .8332
Diabetes .0065
Insulin treated 15,360 (16.21) 6807 (15.92) 873 (17.41)
Non-insulin treated 27,595 (29.12) 12,504 (29.25) 1518 (30.28)
Dialysis 2521 (2.66) 1093 (2.56) 136 (2.71) .4932
Hypertension 83,198 (87.78) 37,497 (87.71) 4418 (88.11) .7012
Chronic lung disease <.0001
Moderate 5803 (6.12) 2590 (6.06) 346 (6.90)
Severe 3900 (4.11) 1814 (4.24) 251 (5.01)
Immunosuppression 2304 (2.43) 1011 (2.36) 139 (2.77) .1995
PVD 13,283 (14.02) 5658 (13.24) 672 (13.40) .0003
CVD .0005
Stroke 6778 (7.15) 2821 (6.60) 334 (6.66)
No stroke 6702 (7.07) 2906 (6.80) 337 (6.72)
Previous PCI 23,660 (93.78) 11,216 (94.05) 1361 (94.32) .4388
Myocardial infarction <.0001
<24 h 1269 (1.34) 588 (1.38) 135 (2.69)
1-21 d 25,947 (27.38) 11,320 (26.48) 1569 (31.29)
>21 d 17,435 (18.40) 7913 (18.51) 846 (16.87)
Unstable angina 35,224 (37.17) 16,375 (38.30) 1924 (38.37) .0001
NYHA functional classification <.0001
Class I-III 11,324 (11.95) 4698 (10.99) 629 (12.54)
Class IV 2817 (2.97) 1172 (2.74) 190 (3.79)
Atrial fibrillation/flutter 5820 (6.14) 2508 (5.87) 360 (7.18) .0008
Inotropes 578 (0.61) 244 (0.57) 36 (0.72) .3833
No. of diseased coronary vessels <.0001
2 16,281 (17.18) 9627 (22.52) 1133 (22.60)
3 76,590 (80.81) 31,058 (72.65) 3508 (69.96)
Left main disease>50% stenosis 29,757 (31.40) 13,219 (30.92) 1523 (30.37) .0948
Aortic valve stenosis 2121 (2.24) 1005 (2.35) 105 (2.09) .3137
Mitral valve stenosis 249 (0.26) 117 (0.27) 15 (0.30) .8631
Aortic valve regurgitation, moderate plus 956 (1.01) 443 (1.04) 49 (0.98) .8711
Mitral valve regurgitation, moderate plus 4250 (4.48) 1854 (4.34) 261 (5.21) .0193
Tricuspid valve regurgitation, moderate plus 1790 (1.89) 885 (2.07) 128 (2.55) .0011
Status, urgent 54,559 (57.57) 24,424 (57.13) 3156 (62.94) <.0001
Data presented as mean  SD, median (IQR), or n (%). SD, Standard deviation; IQR, interquartile range; BSA, body surface area; PVD, peripheral vascular disease;
CVD, cerebrovascular disease; PCI, percutaneous coronary intervention; NYHA, New York Heart Association. *Smoking is not a risk model covariate but was included as a
significant patient characteristic.
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TABLE 3. Operative characteristics
Variable
Moderate hypothermia
(n ¼ 94,777)
Mild hypothermia
(n ¼ 42,750)
Normothermia
(n ¼ 5014) P value
Continuous variables
Blood products transfused intraoperatively (U)
PRBCs <.0001
Mean  SD 1.81  1.58 1.72  1.61 1.82  1.73
Median (IQR) 2 (1-2) 2 (1-2) 2 (1-2)
FFP .0040
Mean  SD 0.63  1.25 0.64  1.26 0.66  1.25
Median (IQR) 0 (0-1) 0 (0-0) 0 (0-1)
Platelets .0618
Mean  SD 1.01  2.36 1.07  2.44 0.93  1.86
Median (IQR) 0 (0-1) 0 (0-1) 0 (0-1)
Cryoprecipitate <.0001
Mean  SD 0.15  1.06 0.31  1.81 0.22  1.27
Median (IQR) 0 (0-0) 0 (0-0) 0 (0-0)
Blood products transfused postoperatively (U)
PRBCs .7006
Mean  SD 2.34  2.33 2.34  2.42 2.38  2.28
Median (IQR) 2 (1-3) 2 (1-3) 2 (1-3)
FFP .0001
Mean  SD 0.59  1.64 0.55  1.61 0.55  1.44
Median (IQR) 0 (0-0) 0 (0-0) 0 (0-0)
Platelets .2295
Mean  SD 0.52  1.78 0.46  1.68 0.48  1.79
Median (IQR) 0 (0-0) 0 (0-0) 0 (0-0)
Cryoprecipitate .0014
Mean  SD 0.18  1.16 0.23  1.48 0.26  1.81
Median (IQR) 0 (0-0) 0 (0-0) 0 (0-0)
Skin incision time (min) <.0001
Mean  SD 243  71.6 224  68.8 216  74.7
Median (IQR) 235 (194-285) 216 (177-262) 206 (165-258)
Total ventilation time (h) <.0001
Mean  SD 17.8  63.8 15.9  55.8 17.0  53.5
Median (IQR) 6.95 (4.58-12.30) 6.32 (4.25-11.25) 6.33 (4.08-12.33)
Total ICU time (h) <.0001
Mean  SD 67.5  94.3 62.1  85.7 65.0  110.2
Median (IQR) 46.5 (25.0-73.7) 44.0 (24.0-71.0) 43.7 (23.8-72.0)
Categorical variables
Intraoperative blood transfusion 33,678 (35.53) 12,523 (29.29) 1532 (30.55) <.0001
Postoperative blood transfusion 36,472 (38.48) 14,719 (34.43) 1801 (35.92) <.0001
Readmission to ICU 2801 (2.96) 1160 (2.71) 153 (3.05) .0395
Data presented as mean SD, median (IQR), or n (%). PRBCs, Packed red blood cells; SD, standard deviation; IQR, interquartile range; FFP, fresh frozen plasma; ICU, intensive
care unit.
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36.0C to 37.6C, and the lower limit of normothermia
would be 36.0C, such as was used in the present study.
In the meta-analysis of 37 studies by Ho and colleagues,3
normothermia was reported to be a temperature of 33.0C
to 38.0C. Furthermore, hypothermia was variously worded
as hypothermia, mild, moderate, moderate-deep, or deep,
usually with 1 break point of temperature that ranged
from 20.0C to 37.0C. The present study adhered to a clear
definition of normothermia and has provided a reasonable
distinction between the hypothermia levels.2716 The Journal of Thoracic and Cardiovascular SurThe 3 cohorts in the present study were significantly
different in baseline patient characteristics. Many of these
factors are known to affect operativemortality. Recognizing
this, each of the STS risk model covariates reported in
Table 2, in addition to those non–risk model covariates
listed in Table 1, was entered into the multivariate analysis
of the effect of temperature on the primary and secondary
outcomes. A total of 39 clinically relevant patient
characteristics were entered into the analysis. Given the
large number of patients in the present study and the robust
nature of the multivariate analysis, additional statisticalgery c December 2014
TABLE 4. Univariate logistic regression analysis of lowest core temperature levels during the procedure and endpoint outcomes
Outcome
Mild vs normothermia Moderate vs normothermia Mild vs moderate hypothermia
Unadjusted OR (95% CI) P value Unadjusted OR (95% CI) P value Unadjusted OR (95% CI) P value
Operative mortality 0.60 (0.49-0.72) <.0001 0.70 (0.58-0.84) .0002 0.86 (0.77-0.95) .0028
Stroke 1.03 (0.76-1.39) .8645 1.19 (0.90-1.57) .2307 0.87 (0.77-0.97) .0125
Infection 1.02 (0.85-1.21) .8680 1.09 (0.91-1.30) .3634 0.93 (0.86-1.01) .0818
Reoperation 0.86 (0.69-1.07) .1809 0.91 (0.73-1.14) .4205 0.94 (0.85-1.04) .2180
OR, Odds ratio; CI, confidence interval.
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was thought not to be indicated.
The effect of hypothermia during cardiac surgery has
been controversial in the reported studies. Ho and
colleagues3 thoroughly reviewed the worldwide published
data on the topic. In their review of 37 studies, they reported
that hypothermia was harmful in 16 studies, not estimable in
13, and beneficial in 8. However, more than one half of the
studies reported on <100 patients. The largest study
contained 1732 patients and used a combined endpoint of
mortality and nonfatal Q-wave myocardial infraction in
its power calculation to determine the sample size.6 That
study showed no difference in the individual or combined
endpoint. The investigators rightly pointed out that
hypothermia can reduce the oxygen demand.6 It is precisely
that which was most likely the source of the association of
hypothermia and reduced operative mortality reported in
the present study.
The strength of the present study was evident in the large
number of subjects in each study group, allowing for
vigorous statistical assessment. The importance of this
statement can be found in a review of the data reported by
Ho and colleagues.3 For comparison, a sample size of
>10,189 patients per group would be required to detect
the difference in their reported mortality rates for
hypothermia (1.9%) versus normothermia (1.4%). This is
assuming 80% power under mortality rate assumptions
consistent with their findings (test of independent
proportions; 2-sided a ¼ 0.05). No other studies have
provided such numbers, apart from the present evaluation.
The main limitations of the present study were selection
bias, unmeasured confounders, and retrospective data
collection. These limitations were most evident in that
the patient characteristics were not equally distributed
among the study groups. Although multivariate analysisTABLE 5. Multivariate logistic regression analysis of lowest core tempera
Outcome
Mild vs normothermia Mod
Adjusted OR (95% CI) P value Adjusted
Operative mortality 0.66 (0.54-0.81) <.0001 0.73
Stroke 1.08 (0.80-1.46) .6211 1.13
Infection 1.09 (0.91-1.30) .3541 1.13
Reoperation 0.86 (0.69-1.08) .2033 0.89
OR, Odds ratio; CI, confidence interval.
The Journal of Thoracic and Carwas used with an extensive list of potential confounders,
unmeasured variables remained a potential bias. The
method of hypothermia grouping was also a concern.
The intent of the present analysis was to address the
treatment decision of the degree of hypothermia as broad
strategies of moderate, mild, and no hypothermia. Although
surgeons often choose an exact temperature goal, the actual
temperature achieved will often be determined by a number
of other factors about the case (eg, patient size, duration of
bypass time). Although a continuous analysis could be used
to identify temperature cutpoints, the estimation of such
cutpoints could be unreliable and subject to overinterpreta-
tion. Finally, a continuous analysis could lead to extreme
estimates in the tails of the distribution where the data are
sparse.
Funding for our project was limited and prevented
additional data analysis and hypothesis testing, with its
attendant implications. To be clear, the data and
analysis established an association between temperature
and operative mortality; however, causality remains
speculative. Also of importance was that the minority of
patients (3.5%) received normothermic perfusion. The
reasoning for such a choice remains unknown and
certainly could have implications on the measured
endpoints. Finally, the findings in our report apply only
to select patients treated with isolated, nonemergency,
on-pump CABG and should not be generalized to other
operative groups (eg, emergency CABG, valve repair or
replacement).
CONCLUSIONS
Most patients in the STS-ACD who underwent
on-pump CABG had a core temperature during the proce-
dure of 36C. Patients who received hypothermia
demonstrated a significant mortality benefit comparedture levels during the procedure and endpoint outcomes
erate vs normothermia Mild vs moderate hypothermia
OR (95% CI) P value Adjusted OR (95% CI) P value
(0.60-0.89) .0015 0.91 (0.82-1.01) .0827
(0.85-1.49) .4063 0.96 (0.85-1.08) .4723
(0.94-1.36) .1823 0.96 (0.89-1.04) .3253
(0.71-1.11) .2952 0.97 (0.88-1.07) .6025
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>36C). Greater degrees of hypothermia (ie,<34C vs
34C) did not result in more benefit. The strength of
our analysis was the large number of subjects in the
database. Additional examination of the data is indicated
to better identify the breakpoint temperature at which
benefit will be derived.
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hypothermic coronary bypass surgery. Lancet. 1994;343:559-63.MMENTARYTo cool or not to cool?Jennifer S. Lawton, MDTo cool or not to cool—that is the question that is raised by
the recent study by Greason and colleagues1 appearing in
this issue of the Journal. Greason and colleagues1 used
the Society of Thoracic Surgeons database to evaluate
patients undergoing nonemergency on-pump isolated
coronary artery bypass grafting (CABG) with specific
attention to the effect of lowest intraoperative recorded
core body temperature on the primary end point of operative
mortality and secondary end points of stroke, reoperation
for bleeding, and a combined infection end point.
The main strength of the study is in the large number of
patients included in the analysis (N ¼ 142,541), because
previous studies have had too few patients to demonstrate
meaningful statistical differences between groups. Patients
were categorized into temperature groups according to the
lowest recorded intraoperative temperature: moderate
hypothermia (34C; N ¼ 94,777), mild hypothermia
(>34C and 36C; N ¼ 42,750), and normothermia
(>36C; N¼ 5014). The study spanned an 18-month period.Univariate analysis demonstrated that mild hypothermia
was better than moderate hypothermia which in turn was
better than normothermia for the end point of operative
mortality; however, operative mortality was 1.5% in the
moderate hypothermia group, 1.3% in the mild hypother-
mia group, and 2.1% in the normothermia group. After
multivariate analysis, mild and moderate hypothermia
were protective relative to normothermia for the primary
end point of operative mortality; however, mild hypother-
mia was not protective relative to moderate hypothermia.
Unfortunately, this large study was retrospective in
nature and involved very different populations and
enrollment biases. Clearly, the normothermic group was
the sickest of all groups; it had more patients with lower
ejection fraction, diabetes mellitus, chronic lung disease,
recent myocardial infarction, unstable angina, higher New
York Heart Association classification, atrial fibrillation or
flutter, and urgent status. The normothermic patient group
also had a higher incidence of readmission to the intensive
care unit. In addition, Greason and colleagues1 excluded
patients with known predictors of operative mortality
(N ¼ 73,780), including reoperation, shock, emergency
status with resuscitation, or salvage, to ‘‘create study
cohorts that were as homogeneous as possible.’’ This may
have introduced additional bias, despite multivariate
adjustment attempts.
Do the results of this study indicate that hypothermia
is good, hyperthermia is bad, or both? Greason and
colleagues1 speculated that hypothermia is protective as a
result of reduced oxygen demand during CABG; however,
does this really affect operative mortality? Hypothermia
may also be detrimental because it is known to be associatedgery c December 2014
